Ledger.Open graph →
SEC Form D · Amendment · filed October 10, 2019

Scipher Medicine Corp

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Samir Kaul · Waltham, MADirectorByron Kalogerou · Waltham, MAExecMichael Rubin · Waltham, MADirectorMiklos Kobor · Waltham, MADirectorJoseph Loscalzo · Waltham, MADirectorAlbert Laszlo Barabasi · Waltham, MADirectorAlif Saleh · Waltham, MAExec · DirectorRaman M. Bindlish · Los Gatos, CADirectorCraig Kasberg · Bellingham, WADirectorNicholas M. Mavris · Los Gatos, CAExec · DirectorForester Capital, L.L.C · Stamford, CTExecDavid J. Kemp · Los Gatos, CADirectorDan Rosen · San Francisco, CADirectorMatt Nichols · San Francisco, CADirectorAlex R. Klabin · Wellesley, MADirectorMatthew R. Satnick · Wellesley, MADirectorPhilippe R. De Montigny · Wellesley, MAExecParas Malde · George Town, Grand Cayman, Cayman IslandsDirectorPatrick Agemian · Grand Cayman, Cayman IslandsDirectorMoerus Capital Management LLC · New York, NYExec · DirectorBart Phillips · Edina, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗